• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨保护素在结肠癌细胞中表达。

Osteoprotegerin is expressed in colon carcinoma cells.

作者信息

Pettersen Ingvild, Bakkelund Wenche, Smedsrød Bård, Sveinbjørnsson Baldur

机构信息

Department of Experimental Pathology, Medical Faculty, University of Tromsø, N-9037, Tromsø, Norway.

出版信息

Anticancer Res. 2005 Nov-Dec;25(6B):3809-16.

PMID:16309167
Abstract

BACKGROUND

Osteoprotegerin (OPG), a soluble member of the tumor necrosis factor family, is produced by various cell types and tissues and plays a key role in the physiological regulation of osteoclast differentiation and activity. Also, OPG is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing factor (TRAIL). In the present study we investigated whether the human colon cancer cell lines HT-29 and SW-480 produce and secrete OPG in vitro.

MATERIALS AND METHODS

Expression of OPG mRNA was examined by RT-PCR. OPG protein was analysed by ELISA assay and immunostaining methods. The effect of OPG secretion on TRAIL-mediated apoptosis was also investigated.

RESULTS

By RT-PCR, it was demonstrated that mRNA transcripts for OPG were produced by both cell lines. By ELISA analysis, OPG was detected in the culture medium; and treatment of cells with proinflammatory cytokines TNF-alpha and IL-1beta increased OPG secretion significantly. Tumor xenografts in nude mice also were shown to express OPG by immunohistochemistry. When RANKL, which selectively binds OPG, was added to cell cultures along with recombinant TRAIL, apoptosis was shown to increase significantly.

CONCLUSION

These data indicate that OPG may be involved in tumorigenesis and the progression of colon cancer.

摘要

背景

骨保护素(OPG)是肿瘤坏死因子家族的可溶性成员,由多种细胞类型和组织产生,在破骨细胞分化和活性的生理调节中起关键作用。此外,OPG是肿瘤坏死因子相关凋亡诱导因子(TRAIL)的可溶性诱饵受体。在本研究中,我们调查了人结肠癌细胞系HT-29和SW-480在体外是否产生和分泌OPG。

材料与方法

通过逆转录聚合酶链反应(RT-PCR)检测OPG mRNA的表达。通过酶联免疫吸附测定(ELISA)和免疫染色方法分析OPG蛋白。还研究了OPG分泌对TRAIL介导的细胞凋亡的影响。

结果

通过RT-PCR证明两种细胞系均产生OPG的mRNA转录本。通过ELISA分析,在培养基中检测到OPG;用促炎细胞因子肿瘤坏死因子-α(TNF-α)和白细胞介素-1β(IL-1β)处理细胞可显著增加OPG分泌。裸鼠体内的肿瘤异种移植物通过免疫组织化学也显示表达OPG。当将选择性结合OPG的核因子κB受体活化因子配体(RANKL)与重组TRAIL一起添加到细胞培养物中时,细胞凋亡显著增加。

结论

这些数据表明OPG可能参与结肠癌的肿瘤发生和进展。

相似文献

1
Osteoprotegerin is expressed in colon carcinoma cells.骨保护素在结肠癌细胞中表达。
Anticancer Res. 2005 Nov-Dec;25(6B):3809-16.
2
Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically.乳腺癌细胞中骨保护素的过表达增强原位和骨肿瘤生长,且与治疗性给药的情况相反。
Cancer Res. 2006 Apr 1;66(7):3620-8. doi: 10.1158/0008-5472.CAN-05-3119.
3
Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.人骨髓基质细胞可保护前列腺癌细胞免受TRAIL诱导的凋亡。
J Bone Miner Res. 2004 Oct;19(10):1712-21. doi: 10.1359/JBMR.040703. Epub 2004 Jul 7.
4
Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.脂多糖通过诱导白细胞介素-1β和肿瘤坏死因子-α刺激牙周膜成纤维细胞中骨保护素和核因子κB受体激活剂配体的表达。
Bone. 2004 Sep;35(3):629-35. doi: 10.1016/j.bone.2004.04.023.
5
Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.骨保护素是肿瘤坏死因子相关凋亡诱导配体/Apo2配体的可溶性诱饵受体,可作为人骨髓瘤细胞的旁分泌生存因子发挥作用。
Cancer Res. 2003 Mar 1;63(5):912-6.
6
Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.前列腺细胞对TRAIL诱导的细胞凋亡的敏感性随肿瘤进展而增加:死亡受体5(DR5)和半胱天冬酶8是关键因素。
Prostate. 2006 Jun 15;66(9):987-95. doi: 10.1002/pros.20421.
7
Down-regulation of osteoprotegerin production in bone marrow macrophages by macrophage colony-stimulating factor.巨噬细胞集落刺激因子对骨髓巨噬细胞中骨保护素生成的下调作用。
Cytokine. 2005 Aug 21;31(4):288-97. doi: 10.1016/j.cyto.2005.03.009.
8
Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.骨保护素(OPG)是人类前列腺癌细胞的一种生存因子。
Cancer Res. 2002 Mar 15;62(6):1619-23.
9
Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland.甲状腺中核因子κB受体活化因子配体及骨保护素的检测与特性分析
J Cell Biochem. 2002;86(4):642-50. doi: 10.1002/jcb.10242.
10
Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.原发性甲状旁腺功能亢进症中骨保护素及核因子κB受体活化因子配体mRNA水平的骨骼变化:甲状旁腺切除的影响及其与骨代谢的关联
Bone. 2004 Jul;35(1):256-65. doi: 10.1016/j.bone.2004.03.012.

引用本文的文献

1
Proteome-wide analysis reveals potential therapeutic targets for Colorectal cancer: a two-sample mendelian randomization study.蛋白质组学分析揭示结直肠癌的潜在治疗靶点:两样本孟德尔随机化研究。
BMC Cancer. 2023 Dec 4;23(1):1188. doi: 10.1186/s12885-023-11669-6.
2
Osteoprotegerin, Parathyroid Hormone and Vitamin D as Effective Factors on Serum-Urine Calcium Levels in Breast Cancer Patients.骨保护素、甲状旁腺激素和维生素 D 对乳腺癌患者血清-尿液钙水平的影响。
Arch Razi Inst. 2022 Oct 31;77(5):1975-1986. doi: 10.22092/ARI.2022.358485.2226. eCollection 2022 Oct.
3
p57Kip2 is an essential regulator of vitamin D receptor-dependent mechanisms.
p57Kip2 是维生素 D 受体依赖性机制的必需调节因子。
PLoS One. 2023 Feb 15;18(2):e0276838. doi: 10.1371/journal.pone.0276838. eCollection 2023.
4
Escaping cell death via TRAIL decoy receptors: a systematic review of their roles and expressions in colorectal cancer.通过 TRAIL 诱饵受体逃避细胞死亡:结直肠癌中它们的作用和表达的系统评价。
Apoptosis. 2022 Dec;27(11-12):787-799. doi: 10.1007/s10495-022-01774-5. Epub 2022 Oct 7.
5
Colorectal Cancer and Bone Tissue: Fantastic Relations and Where to Find Them.结直肠癌与骨组织:奇妙的关系及其所在之处
Cancers (Basel). 2020 Jul 24;12(8):2029. doi: 10.3390/cancers12082029.
6
Downregulation of osteoprotegerin expression in metastatic colorectal carcinoma predicts recurrent metastasis and poor prognosis.转移性结直肠癌中骨保护素表达下调预示着复发转移和不良预后。
Oncotarget. 2016 Nov 29;7(48):79319-79326. doi: 10.18632/oncotarget.12686.
7
Osteoprotegerin rich tumor microenvironment: implications in breast cancer.富含骨保护素的肿瘤微环境:对乳腺癌的影响
Oncotarget. 2016 Jul 5;7(27):42777-42791. doi: 10.18632/oncotarget.8658.
8
Down-regulation of osteoprotegerin expression as a novel biomarker for colorectal carcinoma.骨保护素表达下调作为结直肠癌的一种新型生物标志物
Oncotarget. 2016 Mar 22;7(12):15187-99. doi: 10.18632/oncotarget.7885.
9
Serum osteoprotegerin and future risk of cancer and cancer-related mortality in the general population: the Tromsø study.血清护骨素与一般人群癌症及癌症相关死亡率的未来风险:特罗姆瑟研究。
Eur J Epidemiol. 2015 Mar;30(3):219-30. doi: 10.1007/s10654-014-9975-3. Epub 2014 Dec 2.
10
Osteoprotegerin (OPG) and related proteins (RANK, RANKL and TRAIL) in thyroid disease.甲状腺疾病中的骨保护素 (OPG) 及其相关蛋白 (RANK、RANKL 和 TRAIL)。
World J Surg. 2011 Sep;35(9):1984-92. doi: 10.1007/s00268-011-1185-5.